1. Home
  2. Analysis

Hyperventilation and drugs of ingredients of pectin (a real world drug study)


Summary:

Hyperventilation is found among people who take drugs with ingredients of pectin, especially for people who are male, 60+ old , have been taking the drugs for < 1 month. This phase IV clinical study is created by eHealthMe based on reports of 2,947 people who have side effects when taking drugs with ingredients of pectin from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Apple pectin, Citrus pectin, Grapefruit pectin, Lemon pectin, Mcp, Modified citrus pectin, Pectin, Pectinic acid.

On Oct, 13, 2025

2,947 people reported to have side effects when taking drugs with ingredients of pectin.
Among them, 17 people (0.58%) have Hyperventilation

What is Hyperventilation?

Hyperventilation is found to be associated with 867 drugs and 1,429 conditions by eHealthMe. Check the latest studies of Hyperventilation.

Number of reports submitted per year:

Could drugs with ingredients of pectin cause Hyperventilation?

Time on drugs with ingredients of pectin when people have Hyperventilation *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Hyperventilation when taking drugs with ingredients of pectin *:

  • female: 47.06 %
  • male: 52.94 %

Age of people who have Hyperventilation when taking drugs with ingredients of pectin *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 12.5 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 87.5 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. High Blood Pressure: 15 people, 88.24%
  2. Type 2 Diabetes: 9 people, 52.94%
  3. Depression: 7 people, 41.18%
  4. Nausea (feeling of having an urge to vomit): 6 people, 35.29%
  5. Hepatic Pain (pain in liver): 6 people, 35.29%
  6. Diverticulum Intestinal (a pouch that is attached to the first part of the small intestine): 6 people, 35.29%
  7. Diarrhea: 6 people, 35.29%
  8. Diabetes: 6 people, 35.29%
  9. Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 6 people, 35.29%
  10. Lung Cancer - Non-Small Cell (lung cancer): 1 person, 5.88%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Victoza: 9 people, 52.94%
  2. Valsartan: 9 people, 52.94%
  3. Torsemide: 9 people, 52.94%
  4. Telmisartan: 9 people, 52.94%
  5. Symbicort: 9 people, 52.94%
  6. Metformin Hydrochloride: 9 people, 52.94%
  7. Lyrica: 9 people, 52.94%
  8. Jardiance: 9 people, 52.94%
  9. Ibuprofen: 9 people, 52.94%
  10. Esomeprazole Magnesium: 9 people, 52.94%

Other side effects people have besides Hyperventilation *:

You may use this to check any potential undetected side effects.

  1. C-Reactive Protein Increased: 15 people, 88.24%
  2. Depression: 15 people, 88.24%
  3. Diarrhea: 10 people, 58.82%
  4. Pneumonia: 10 people, 58.82%
  5. Dry Mouth: 9 people, 52.94%
  6. General Physical Health Deterioration (weak health status): 9 people, 52.94%
  7. Gastrointestinal Disorder (functional problems of gastrointestinal tract): 9 people, 52.94%
  8. Feeling Abnormal: 9 people, 52.94%
  9. Fear: 9 people, 52.94%
  10. Fatigue (feeling of tiredness): 9 people, 52.94%

* Approximation only. Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drugs with ingredients of pectin, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on pectin. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2025 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.